Net Income
Net Income
Moderna Net Income decreased by 62.6% to -$1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.3%, from -$971.00M to -$1.34B. Over 4 years (FY 2021 to FY 2025), Net Income shows a downward trend with a -30.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.78B | $3.33B | $4.87B | $3.66B | $2.20B | $1.04B | $1.47B | $79.00M | -$1.38B | -$3.63B | $0.00 | -$1.18B | -$1.28B | $13.00M | -$1.12B | -$971.00M | -$825.00M | -$200.00M | -$826.00M | -$1.34B |
| QoQ Change | — | +19.9% | +46.1% | -24.9% | -39.9% | -52.5% | +40.5% | -94.6% | <-999% | -163.0% | +100.0% | — | -8.9% | +101.0% | <-999% | +13.3% | +15.0% | +75.8% | -313.0% | -62.6% |
| YoY Change | — | — | — | — | -21.0% | -68.7% | -69.9% | -97.8% | -162.8% | -448.0% | -100.0% | <-999% | +7.3% | +100.4% | — | +17.4% | +35.5% | <-999% | +26.3% | -38.3% |
Range-$3.63B – $4.87B
CAGR-14.2%
Avg YoY Growth-269.7%
Median YoY Growth-68.7%
Current Streak2 quarters decline
Net Income at Other Companies
Frequently Asked Questions
- What is Moderna's net income?
- Moderna (MRNA) reported net income of -$1.34B in Q1 2026.
- How has Moderna's net income changed year-over-year?
- Moderna's net income decreased by 38.3% year-over-year, from -$971.00M to -$1.34B.
- What is the long-term trend for Moderna's net income?
- Over 4 years (2021 to 2025), Moderna's net income has grown at a -30.7% compound annual growth rate (CAGR), from $12.20B to -$2.82B.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.